期刊文献+

心肺复苏过程中进行溶栓治疗的Meta分析 被引量:25

Meta-analysis of thrombolysis and non-thrombolysis in cardiopulmon ary resuscitation
原文传递
导出
摘要 目的根据现有临床研究评价对心肺复苏过程中进行溶栓治疗的有效性和安全性。方法从1966-01-01-2004-08-01MEDLINE光盘数据库,检索以心跳骤停后进行心肺复苏术的患者为研究对象,比较溶栓与非溶栓治疗效果的临床研究文献,并对文献结果进行Meta分析。结果共9篇临床研究文献入选。心肺复苏过程中进行溶栓治疗可以显著提高自主循环恢复率、24小时存活率、出院率并改善远期神经功能(P<0·01)。相比非溶栓治疗,溶栓治疗显著增加了严重性出血的发生率(P<0·01)。结论与非溶栓治疗比较,溶栓治疗增加了的严重性出血的发生率。但从整体而言,心肺复苏术过程中进行溶栓治疗可以显著提高患者的出院率并改善远期神经功能。 Objective To evaluate the efficacy and safety of thrombolysis in cardiopulmonary resuscitation (CPR).Methods The efficacy or safety of thrombolysis and non- thrombolysis in CPR were chosen and compared from MEDLINE disks from 1966 to August of 2004. A Meta-analysis was applied to evaluate the results of the two therapies. Results Nine clinical thesises were analyzed. Compared with non-thrombolysis, the rate of spontaneous circulation return, survival time more than 24-hours, survival to discharge and improved neurological function in patients with CPR treated with thrombolysis were significant higher (P 〈 0.01 ), but the rate of major bleeding was higher too. Conclusion Thrombolysis increases the risk of major bleeding, but it could markly improve the rate of survival to discharge and improve neurological function in patients with CPR on the whole.
出处 《中华急诊医学杂志》 CAS CSCD 2005年第8期651-654,共4页 Chinese Journal of Emergency Medicine
基金 广州市重大科技攻关项目(2004Z3-E0381)
关键词 心肺复苏术 溶栓疗法 META 血栓溶解疗法 神经功能 Cardiopulmonary resuscitation Thrombolytic therapy Therapeutics Meta-analysis
  • 相关文献

参考文献12

  • 1Janata K, Holzer M, Kurkciyan I, et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism. Resuscitation, 2003,57 (1): 49-55.
  • 2Kurkciyan I, Meron G, Sterz F, et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment. J Intern Med, 2003, 253 (2): 128-135.
  • 3Schreiber W, Gabriel D, Sterz F, et al. Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. Resuscitation,2002, 52 (1): 63-69.
  • 4Lederer W, Lichtenberger C, Pechlaner C, et al. Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation, 2001, 50 (1): 71-76.
  • 5Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, et al.Efficacy of thrombolysis in patients with acute myocardial infarction requiring cardiopulmonary resuscitation. Inten Care Med, 2001 Jun; 27(6): 1050-1057
  • 6Bottiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet, 2001, 19; 357(9268): 1583-1585.
  • 7Bulut S, Aengevaeren WR, Luijten HJ, et al. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? Resuscitation, 2000, 47 (2): 155-161.
  • 8Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med, 2000,160 (10): 1529-1535.
  • 9van Campen LC, van Leeuwen GR, Verheugt FW. Safety and efficacy of thrombolysis for acute myocardial infarction in patients with prolonged out-of-hospital cardiopulmonary resuscitation. Am J Cardiol, 1994, 73(13): 953-955.
  • 10Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med, 2004, 350 (2): 105-113.

同被引文献277

引证文献25

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部